baber/WOPTO huggingface dataset:
Patent NZ-560696-A (NZ)
Title: Use of erythropoietin based medicaments for the protection of a mammal from pathology resulting from injury to excitable tissue
Inventor: BRINES MICHAEL
IPC: A61P25/28
Filed: 2000-04-13
Abstract: Disclosed is the use of erythropoietin (EPO), an EPO receptor activity modulator, an EPO-activated receptor modulator, or a combination of at least two thereof for preparing a pharmaceutical composition for the protection of a mammal from pathology resulting from injury to excitable tissue, wherein said EPO, EPO receptor activity modulator, or EPO-activated receptor modulator is capable of activating EPO receptors of excitable tissue, wherein the pharmaceutical composition is for peripheral administration in a non-toxic amount effective to achieve said protective effect, wherein the pharmaceutical composition is for administration before or after the onset of the injury, and wherein said injury is the result of Friedrich's ataxia, multiple sclerosis, amyotrophic lateral sclerosis, brain ischemia, stroke, or the result of injury to retinal tissue (such as retinal ischemia or retinal trauma).
Patent NZ-561868-A (NZ)
Title: Roller support assemblies
Inventor: PROCTOR NIGEL
Filed: 2007-09-24
Abstract: Rollers are installed into a housing so that stub axles pass through a fully enclosed openings and engagement surfaces are provided on the inner part of the housing so that it is splayed apart as the rollers are moved into the housing until the stub axles engage in the respective holes.
Patent NZ-569990-A (NZ)
Title: A top carrier package for containers
Inventor: OLIVEIRA STEVEN MANUEL
IPC: B65D71/46
Filed: 2007-01-30
Abstract: Disclosed is a package with a plurality of containers held thereby, the containers having top flange portions. The package includes panels that extend at least partially around an interior of the package. The panels include a top panel, a bottom panel, and an intermediate panel. The bottom panel includes plurality of bottom apertures each of which partially receives a container of the plurality of containers. The intermediate panel includes a plurality of intermediate apertures each of which partially receives a container. The package further includes at least one retention flap foldably attached to the intermediate panel adjacent to each intermediate aperture. The retention flap is for providing a retention force by engaging an underside or shoulder of the top flange portion of the respective container, to restrain the container from removal from the package. The top flange portions of the containers are disposed within the interior of the package.
Patent NZ-572177-A (NZ)
Title: Anti-dll4 antibodies and methods using same
Inventor: YAN MINHONG
IPC: C12N15/13
Filed: 2007-06-06
Abstract: Disclosed is an isolated anti-DLL4 antibody comprising six hypervariable region (HVR) sequences: (i) HVR-L1 comprising sequence A1-A11, wherein A1-A11 is RASQDVSTAVA (SEQ ID NO: 10) (ii) HVR-L2 comprising sequence B1-B7, wherein B1-B7 is SASFLYS (SEQ ID NO:11) (iii) HVR-L3 comprising sequence C1-C9, wherein C1-C9 is QQSYTGTVT(SEQ ID NO:18) (iv) HVR-H1 comprising sequence D1-D10, wherein D1-D10 is GFTFTDNWIS (SEQ ID NO:1); (v) HVR-H2 comprising sequence E1-E18, wherein E1-E18 is GYISPNSGFTYYADSVKG (SEQ ID NO:8) and (vi) HVR-H3 comprising sequence F1-F15, wherein F1-F15 is VYYCARDNFGGYFDY (SEQ ID NO:9). Also disclosed is the use of the antibody in the manufacture of a medicament for treating a tumor, cancer, or cell proliferative disorder.
Patent NZ-574364-A (NZ)
Title: Electrical safety devices and systems for use with electrical wiring, and methods for using same
Inventor: SEXTON ROBERT JAY
IPC: G01R31/58
Filed: 2007-07-24
Abstract: A method for monitoring an electrical flat wire terminated between a source and a destination is disclosed. The method includes testing one or more conductors of the electrical flat wire for at least one of miswires, wire faults or abnormal conditions; and controlling communication of an electrical power signal from a power source to the electrical flat wire based at least in part on results of the testing. Systems using the method are also disclosed.
Patent NZ-574664-A (NZ)
Title: Combination treatment for metabolic disorders comprising an incretin mimetic such as exendin or a dppv iv inhibitor
Inventor: WOLPE STEPHEN D
IPC: A61K31/19
Filed: 2007-08-16
Abstract: Disclosed is the use of a compound of formula (I) (or a pharmaceutically acceptable salt thereof) and an incretin mimetic in the manufacture of a combination for treatment of a condition selected from the group consisting of insulin resistance syndrome, diabetes, and polycystic ovary syndrome; or for the treatment or reduction in the chance of developing atherosclerosis, arteriosclerosis, obesity, hypertension, hyperlipidemia, fatty liver disease, nephropathy, neuropathy, retinopathy, foot ulceration or cataracts associated with Type II diabetes; or for the treatment of a condition selected from the group consisting of hyperlipidemia, cachexia, and obesity; wherein the incretin mimetic is selected from the group consisting of an exendin, an exendin agonist, a non-peptide small molecule GLP-1 receptor agonist, their polymer-modified and acylated forms, and pharmaceutically acceptable salts, hydrates, and solvates, and hydrates and solvates of such salts; m is 0, 2 or 4; and X is hydroxy or alkoxy; R6 is hydrogen, carbonyl or hydroxy; and three of R1, R2, R3, R4 and R5 are hydrogen and the remainder are independently selected from the group consisting of hydrogen, halo, hydroxy, methyl, ethyl, perfluoromethyl, methoxy, ethoxy, and perfluoromethoxy; or X is -NR8R9, wherein R8 is hydrogen or hydroxy and R9 is hydrogen, methyl or ethyl; R6 is hydrogen; and three of R1, R2, R3, R4 and R5 are hydrogen and the remainder are independently selected from the group consisting of hydrogen, halo, methyl, ethyl, perfluoromethyl, methoxy, ethoxy, and perfluoromethoxy. Of particular importance is the use of compounds of general formula (I) which are selected from 4-(3-(2,6-dimethylbenzyloxy)phenyl)-4-oxobutyric acid, 3-(2,6-dimethylbenzyloxy)phenylacetic acid, 4-(3-(2,6-dimethylbenzyloxy)-phenyl)-4(R)-hydroxybutanoic acid and N-hydroxy-2-[3-(2,6-dimethylbenzyloxy)phenyl]acetamide.
Patent NZ-577736-A (NZ)
Title: Oral disinfectant, and food additive comprising the disinfectant
Inventor: SHIN KOUICHIROU
IPC: A61K31/198
Filed: 2007-06-28
Abstract: Disclosed is the use of lactoperoxidase, glucose oxidase, glucose, and an organic acid and/or an organic acid salt as active ingredients in the manufacture of a pharmaceutical composition for prevention and/or treatment of periodontal disease, oral malodor, or aspiration pneumonia, wherein the pH of the pharmaceutical composition is adjusted from 4.4 to 5.4 by the organic acid and/or the organic acid salt, wherein the organic acid is at least one acid selected from the group consisting of citric acid, lactic acid, malic acid, succinic acid, tartaric acid, and glutamic acid, and wherein the pharmaceutical composition does not contain thiocyanate added as an active ingredient. Also disclosed is the use of lactoperoxidase, glucose oxidase, glucose, and an organic acid and/or an organic acid salt as active ingredients in the manufacture of a pharmaceutical composition wherein the pharmaceutical composition is formulated as an oral disinfectant, or as a food additive.
Patent NZ-583274-A (NZ)
Title: Mask cushion including membrane, undercushion and flexible element
Inventor: BERTHON-JONES MICHAEL
IPC: A61M16/06
Filed: 2003-11-06
Abstract: A cushion assembly for a mask used for treatment of sleep disordered breathing, the cushion assembly comprising: a cushion flange (140) of relatively rigid material; an undercushion (120) connected to the rear side of the cushion flange; a membrane (110) connected to the rear side of the cushion flange, the membrane being adapted to engage a wearer's face; and a flexible element (130) disposed between the undercushion. The membrane and the undercushion have differing stiffnesses. The flexible element may have a stiffness intermediate those of the membrane and the undercushion, or may have segments of differing stiffnesses. The flexible element may be supported by a rigid retainer.
Patent NZ-587134-A (NZ)
Title: Protopanaxadiol-type ginsenoside compositions and uses thereof
Inventor: DALEY THOMAS E
IPC: A61P43/00
Filed: 2009-01-23
Abstract: Provided is a ginsenoside composition suitable for administration to a subject consisting of a non-ginsenoside fraction and a ginsenoside fraction, wherein the ginsenoside fraction comprises at least 30% (w/w) of the composition and consists essentially of Rb1, Rb2, Rc and Rd. The composition can be used to ameliorate symptoms of elevated acetaldehyde concentration in a subject.
Patent NZ-588048-A (NZ)
Title: Screening methods
Inventor: WIGLEY PETER
IPC: A01N63/27
Filed: 2011-03-17
Abstract: NZ 588048 Disclosed is a method for the selection of one or more microorganisms capable of imparting one or more beneficial property to a plant, the method comprising at least the steps of: subjecting one or more plant to a growth medium in the presence of one or more microorganisms; applying one or more selective pressure during step a); selecting one or more plant following step b); isolating one or more microorganisms or obtaining one or more microorganism in crude form from said one or more plant and/or plant rhizosphere of said one or more plant selected in step c); wherein, steps a) to d) are repeated one or more times, wherein the one or more microorganisms isolated or obtained in step d) are used in step a) of any successive repeat.
Patent NZ-591827-A (NZ)
Title: Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject
Inventor: WONG WAI MING
IPC: A61K38/04
Filed: 2006-07-21
Abstract: Disclosed is the use of a biologically active peptide having an amino acid sequence comprising SEQ ID NO: 1 in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject. Further disclosed is the use of a biologically active peptide having an amino acid sequence consisting of SEQ ID NO: 1 in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject.
Patent NZ-604027-A (NZ)
Title: Cleaning concentrate and method of cleaning contaminated surfaces
Inventor: DOOLEY JOSEPH B
IPC: C11D1/83
Filed: 2011-06-06
Abstract: NZ 604027 The disclosure relates to a medical instrument cleaning concentrate having an active ingredient consisting essentially of (i) a biofilm permeation agent selected from the group consisting of sodium lauryl sulfate, sodium lauryl ether sulfate, ammonium lauryl sulfate, ammonium lauryl ether sulfate, sophorose biosurfactant, sodium lauroyl sarcosinate, triethanolamine lauroyl-L-glutamate, sodium myristyl sarcosinate, sodium dodecyl sulfate, potassium laurate, sodium dodecane sulfonate, and sodium lauryl ethoxysulfate and (ii) a nonionic alkoxylated alcohol surfactant having an HLB ranging from about 5 to less than about 8, wherein a ratio of (i) to (ii) in the concentrate ranges from about 2:1 to about 5:1, and wherein a wash solution containing the concentrate leaves substantially no residual cleaning agents on the surfaces of the medical instruments subsequent to rinsing the instruments. The medical instrument cleaning concentrate may further comprise inactive ingredients selected from the group consisting of a fragrance oil, a dye, a foaming agent, a propellant, an anti-foam agent, and water.
Patent NZ-610144-A (NZ)
Title: A waste water evaporation system and apparatus
Inventor: THOMAS GEORGE POW
IPC: C02F11/12
Filed: 2012-05-02
Abstract: A covered structure (1) with screens (5) to create turbulence in the air over waste water (4) used in a wastewater stabilisation and evaporation system is disclosed. The structure includes features to accelerate the evaporation of waste liquid and drying of sludge. The invention also relates to a method of treating waste water in an oxidation pond by utilising natural sources such as sunlight and wind and in particular although not solely to such methods and related means for treating waste water.
Patent NZ-611362-A (NZ)
Title: A heterogeneous catalytic reaction apparatus and method
Inventor: MCKINLEY DONALD HUGH
IPC: C07C67/08
Filed: 2012-08-24
Abstract: An apparatus for use in heterogeneous catalytic reactions comprising a column reactor (1) comprising a plurality of trays (2) mounted one above another, each adapted to hold a predetermined liquid volume and a charge of particles of a solid catalyst thereon; means for introducing a liquid phase reactant above the uppermost tray; means for introducing a vapour phase reactant below the lowermost tray; means for removing a liquid phase post-reaction stream from below the lowermost tray; means for removing a vapour phase post-reaction stream from above the uppermost tray; vapour upcomer means (14) associated with each tray (2a, 2b, 2c) adapted to allow vapour to enter that tray from below; underflow means (7) associated with each tray adapted to remove liquid from that tray and the column reactor before being introduced into the column reactor at a lower tray; means for temporarily directing the liquid removed from a tray to bypass at least one lower tray and be reintroduced to the column reactor at a tray located below the at least one bypassed tray; means for removing the liquid and catalyst from the at least one bypassed tray: and means for replacing a liquid and catalyst inventory on the at least one bypassed tray.
Patent NZ-613076-A (NZ)
Title: A composition comprising an antibiotic and a dispersant or an anti -adhesive agent
Inventor: O’NEIL DEBORAH
IPC: A61K31/7036
Filed: 2011-12-14
Abstract: Disclosed is a product comprising an antibiotic agent and a second agent being a dispersant or an anti-adhesive agent, wherein the antibiotic is Tobramycin, Colistin, Gentamicin or Ciprofloxacin and wherein the second agent is cysteamine.
Patent NZ-616871-A (NZ)
Title: Amino acid sequence presenting fusion polypeptide and its use
Inventor: ANDRES HERBERT
IPC: C12N9/90
Filed: 2012-05-04
Abstract: Disclosed is a fusion polypeptide comprising a polypeptide according to formula I: NH2-S2-X1-S1-COOH (formula I) wherein -X1 is a polypeptide selected from the group of GS-X0-GSS (formula VI), AGS-X0-GSS (formula V), CG-X0-GC (formula VI), C-X0-GC (formula VII), G-X0-G (formula VIII), S-X0-GSS (formula IX), GG-X0-GG (formula X), G-X0-TGG (formula XI), GGGS-X0-GGGS (formula XII), GGNP-X0-GPT (formula XIII), -wherein X0 is either a random amino acid sequence or an amino acid sequence derived from a first polypeptide, wherein the first polypeptide is a human polypeptide, -S2 and S1 are non-overlapping amino acid sequences derived from a second polypeptide, and are selected from the following combinations of sequences: (a) S2 has the amino acid sequence SEQ ID NO: 02 (DRGAGC), and S1 has the amino acid sequence SEQ ID NO: 03 (CLIPPASV), (b) S2 has the amino acid sequence SEQ ID NO: 04, and S1 has the amino acid sequence SEQ ID NO: 05, (c) S2 has the amino acid sequence SEQ ID NO: 07, and S1 has the amino acid sequence SEQ ID NO: 08 (LVFDVELLKLE), (d) S2 has the amino acid sequence SEQ ID NO: 10, and S1 has the amino acid sequence SEQ ID NO: 11, and S2 has the amino acid sequence SEQ ID NO: 107, S1 has the amino acid sequence SEQ ID NO: 108; and - “-” denotes a peptide bond. Also disclosed is the use of such a fusion polypeptide for epitope mapping, whereby the amino acid sequence of X1 comprises the epitope.
Patent NZ-626657-A (NZ)
Title: Slip ring assembly
Inventor: BEEKMANN ALFRED
IPC: H01R43/14
Filed: 2013-01-11
Abstract: Disclosed is a slip ring transmitter (400) and method for making one. The slip ring transmitter (400) includes gold slip ring (202) with grooves formed by contact with gold wires, and multi-brush bunches (306) on a multi-brush board (304). The method for reconditioning the slip ring transmitter (400) includes the steps of removing a gold wire board from the slip ring transmitter (400) and fitting the multi-brush board (304) as a replacement for the gold wire board.
Patent NZ-630721-A (NZ)
Title: Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
Inventor: CARSON KENNETH GORDON
IPC: C07D487/04
Filed: 2013-03-05
Abstract: Pyrazolo[1,5-a]pyrimidine-based compounds of the formula are disclosed, wherein R1, R2 and R3 are defined herein. Compositions comprising the compounds and methods of their use to treat, manage and/or prevent diseases and disorders mediated by mediated by adaptor associated kinase 1 activity are also disclosed. As example of the compound is (S)-1-(2-(((3-(2-methoxyphenyl)pyrazolo[1,5-a]pyrimidin-5-yl)amino)methyl)pyrrolidin-1-yl)-3,3-dimethylbutan-1-one.
Patent NZ-712409-A (NZ)
Title: A method of preparing pure precious metal nanoparticles with large fraction of (100) facets, nanoparticles obtained by this method and their use
Inventor: LEWERA ADAM
IPC: B22F9/24
Filed: 2014-07-03
Abstract: The invention provides a method of preparing pure precious metal nanoparticles of controlled sizes and having (100) facets, wherein a precursor substance contained in a reagent solution is subjected to a reduction reaction using a reducing agent contained in the reagent solution to provide nanoparticles, and the reduction reaction is stopped by rapid lowering of the reaction solution temperature. In the process of the invention, the need to use surfactants or other organic particles to stabilize the (100) facets is eliminated.
Patent NZ-713039-A (NZ)
Title: Water hardness monitoring via fluorescence
Inventor: KAHAIAN ARTHUR J
IPC: G01N33/18
Filed: 2014-02-12
Abstract: Provided are automated methods for measuring soluble magnesium concentration in water using fluorescence. The methods employ the use of a pH-buffered liquid and a magnesium coordinating fluorescing reagent. In certain embodiments, the methods may further employ measuring total hardness concentration of the water by displacing any soluble calcium with soluble magnesium and then re-measuring the soluble magnesium concentration. Optionally, the soluble calcium concentration can be determined by subtracting the measured soluble magnesium concentration from the measured total hardness concentration.
Patent NZ-738996-A (NZ)
Title: Container with a fitment
Inventor: LAIB DOUGLAS
IPC: B65D47/00
Filed: 2013-08-29
Abstract: A product includes a non-glass container including a neck having a cylindrical interior surface and an internal step, and a fitment coupled to the neck of the container via an interference fit. An outer wall of the fitment has an exterior circumferential surface, an interior circumferential surface, and a tapered surface between the circumferential surfaces at an interior end of the fitment to establish an edge located against the internal step of the container neck that discourages attempts to remove the fitment from the container. The outer wall has an axial length such that the outer wall bottoms out at the internal step in the container and extends out of the container to an outer axial end of the fitment.
Patent NZ-744196-A (NZ)
Title: Viscosity and stability modified ultrasound gel
Inventor: SCURTESCU CRISTIAN
IPC: A61N7/00
Filed: 2016-12-09
Abstract: An ultrasound gel comprising carbomer homopolymer Type B, cellulose nanocrystals and glycerine. The gel has an acoustic impedance of 1.45 to 1.60 MRayls and can be safely used internally or orally. The gel can be sterilized by exposure to gamma-radiation and substantially retains its viscosity. The invention also relates to a method of altering the viscosity of a gel after exposure to gamma-radiation by use of cellulose nanocrystals at a concentration of between 4% and 15% of the gel by weight.
Patent NZ-751188-A (NZ)
Title: Container with a medal
Inventor: SMITH ROGER
IPC: B65D55/06
Filed: 2014-03-06
Abstract: This invention provides a container with a medal retained thereto as an attractive marker for tracking, anti-counterfeiting, tamper-indicating, and/or use-indicating purposes. The container is composed of glass that includes a wall having a pocket, and a medal composed of metal and retained to the wall by container material of integral one-piece construction with the wall and extending over at least a portion of the medal, wherein the container is formed and, downstream, the medal is retained by after-mold deformation of at least a portion of a periphery of the pocket over the medal so that the medal is non-removably retained to the container. The medal of the container is therefore non-removably retained to corresponding wall(s) of the containers so that the medals cannot be removed without destroying or damaging the containers, such that the medals serve as tracking, anti-counterfeiting, tamper-indicating, and/or use-indicating authentication markers.
Patent NZ-757333-A (NZ)
Title: Objects and methods for building small muscle fibers and nerves using fluid disposed in the objects
Inventor: BRUMMOND DARREN
IPC: A63B69/00
Filed: 2018-02-23
Abstract: The present disclosure provides for various objects (weights, playing apparatuses, balls, clothing, etc.) that have liquid disposed in them to assist in building and strengthening small muscle fibers and/or nerves. The various objects can include weights, playing apparatuses such as objects that can be swung in sports, balls, and clothing or other objects that can be worn by humans or other animals. The objects include fluid paths and redirections walls disposed within the fluid paths to direct fluid flow to particular areas within the objects. The designated areas to where fluid flow is directed aid in development of small muscle fibers and/or nerves due to the fluid sloshing around at those particular locations. Methods of making and using the various objects disclosed are also provided.
Patent NZ-769267-A (NZ)
Title: Apparatus for assessing skin reactivity to an implant material
Inventor: DRZALA MARK
IPC: A61K49/00
Filed: 2019-04-08
Abstract: This disclosure provides an apparatus for assessing skin reactivity to a test material, e.g., an implant material. The apparatus includes a holder (110) and a test material unit (120). The holder further comprises a test portion (112) and a holding portion (114). The test portion comprises a concave housing compartment (112a) with an opening facing towards the skin of a subject when the apparatus is worn. The concave housing compartment is adapted to receive and contact the test material unit therein. The periphery of the test material unit matches the shape of an inner surface of the concave housing compartment. The holding portion is configured to cause the test material unit to directly contact with the skin, without using an adhesive. The test material unit comprises an implant material and is mounted to the concave housing compartment of the holder. A method of assessing skin reactivity is also provided.
Patent NZ-774237-A (NZ)
Title: Patient interface with blowout prevention for seal-forming portion
Inventor: SCHEINER RUPERT
IPC: A61M16/06
Filed: 2016-03-24
Abstract: One form of the present technology includes a sealing structure to seal against a user’s face around the user’s airways. The sealing structure includes a flap or membrane that extends inward towards the user’s airways and includes a structure that prevents an inner boundary of the flap or membrane from being blown outwards (e.g., folded backwards upon itself) due to internal pressurization. The invention is a patient interface that comprises a plenum chamber including a plenum chamber inner port, a sealing structure, a positioning and stabilising structure including a decoupling feature and a washout vent structure. The sealing structure comprises a tie that extends between a first interior surface region and a second interior surface region, where the first interior surface region is spaced from the second interior surface region. The tie bounds a space that is open to the plenum chamber.